Top News
Trending Stories
TDB-DST supports Acrannolife Genomics for indigenous manufacturing of advanced IVD diagnostic...
The project focuses on establishing an advanced manufacturing facility to support the large-scale production and deployment of indigenous in-vitro diagnostic (IVD) solutions developed by the company.
Shreehas Tambe appointed CEO & MD of Biocon Limited, effective April...
He will take over from Siddharth Mittal who served the company as Chief Financial Officer and later as CEO & Managing Director, for over 13 years
Maharashtra poised to emerge as a global hub for integrated healthcare...
Chief Minister Devendra Fadnavis, Maharashtra was speaking after inauguration of PULSE 2026, India’s leading Healthcare and Medical Education Summit in Mumbai
Agriculture
ELMED Life Sciences raises $2.7 Million in Series A funding from...
This investment will support the company’s next phase of growth, focused on expanding its manufacturing, strengthening R&D, and scaling distribution across key markets
Education
Manipal Academy of Higher Education secures BSL-3 lab certification, boosting high-containment...
This achievement substantially enhances MAHE's research, diagnostic, and training capabilities
Reader’s Choice
Face to Face
“Research must be designed for translation, not just for publications”: Dr...
Dr Sagar Sengupta, Director, National Institute of Biomedical Genomics (NIBMG) and Director (Additional Charge), National Brain Research Centre (NBRC) shared his insights on the latest initiatives, importance of industry-academia collaboration, increased government funding, and evolution of research ecosystem
Chat with BioVoice
“Biologics and biosimilars represent Veeda’s second-highest strategic priority after clinical trials”
Binoy Gardi, Managing Director and Group CEO, Veeda Lifesciences shared insights on his latest role and top priorities; the company's latest initiatives, outcomes of key acquisitions and future plans
